Safety and efficacy of COVID-19 convalescent plasma in severe pulmonary disease: A report of 17 patients

Affiliations

¹ Deming Department of Medicine, Tulane University, New Orleans, Louisiana, USA.
² Section of Hematology and Medical Oncology, Deming Department of Medicine, Tulane University, New Orleans, Louisiana, USA.
³ Department of Microbiology and Immunology, Tulane University, New Orleans, Louisiana, USA.
⁴ Clinical Research Department, Tulane Cancer Center, Tulane University, New Orleans, Louisiana, USA.
⁵ Department of Medicine, Louisiana State University School of Medicine, New Orleans, Louisiana, USA.
⁶ Section of Infectious Diseases, Deming Department of Medicine, Tulane University, New Orleans, Louisiana, USA.
⁷ Section of Pulmonary Disease, Critical care and Environmental Medicine, Deming Department of Medicine, Tulane University, New Orleans, Louisiana, USA.
⁸ Department of Pulmonary Diseases, Touro LCMC Health, New Orleans, Louisiana, USA.
⁹ Section of Pathology and Laboratory Medicine, Deming Department of Medicine, Tulane University, New Orleans, Louisiana, USA.
¹⁰ Department of Biochemistry and Molecular Biology, Tulane University, New Orleans, Louisiana, USA.
¹¹ Section of Pediatric Infectious Disease, Department of Pediatrics, Tulane University, New Orleans, Louisiana, USA.

Comment

Priya Pal et al. Transfus Med. 2021 Jun.

. 2021 Jun;31(3):217-220.

doi: 10.1111/tme.12729. Epub 2020 Oct 19.

¹ Deming Department of Medicine, Tulane University, New Orleans, Louisiana, USA.
² Section of Hematology and Medical Oncology, Deming Department of Medicine, Tulane University, New Orleans, Louisiana, USA.
³ Department of Microbiology and Immunology, Tulane University, New Orleans, Louisiana, USA.
⁴ Clinical Research Department, Tulane Cancer Center, Tulane University, New Orleans, Louisiana, USA.
⁵ Department of Medicine, Louisiana State University School of Medicine, New Orleans, Louisiana, USA.
⁶ Section of Infectious Diseases, Deming Department of Medicine, Tulane University, New Orleans, Louisiana, USA.
⁷ Section of Pulmonary Disease, Critical care and Environmental Medicine, Deming Department of Medicine, Tulane University, New Orleans, Louisiana, USA.
⁸ Department of Pulmonary Diseases, Touro LCMC Health, New Orleans, Louisiana, USA.
⁹ Section of Pathology and Laboratory Medicine, Deming Department of Medicine, Tulane University, New Orleans, Louisiana, USA.
¹⁰ Department of Biochemistry and Molecular Biology, Tulane University, New Orleans, Louisiana, USA.
¹¹ Section of Pediatric Infectious Disease, Department of Pediatrics, Tulane University, New Orleans, Louisiana, USA.

No abstract available

Comment on

Convalescent plasma or hyperimmune immunoglobulin for people with COVID-19: a rapid review.
Valk SJ, Piechotta V, Chai KL, Doree C, Monsef I, Wood EM, Lamikanra A, Kimber C, McQuilten Z, So-Osman C, Estcourt LJ, Skoetz N. Valk SJ, et al. Cochrane Database Syst Rev. 2020 May 14;5(5):CD013600. doi: 10.1002/14651858.CD013600. Cochrane Database Syst Rev. 2020. Update in: Cochrane Database Syst Rev. 2020 Jul 10;7:CD013600. doi: 10.1002/14651858.CD013600.pub2. PMID: 32406927 Free PMC article. Updated.